Home > Insider Trading > Filing (0000899243-23-019969)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1805387	Cerevel Therapeutics Holdings Inc.	CERE	()	DE

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1040508	Bain Capital Investors Llc	200 Clarendon Street Boston MA 02116	No	No	Yes	No
1706270	Bain Capital Fund Xii, Lp	200 Clarendon Street Boston MA 02116	No	No	Yes	No
1829130	Bcpe Perception Gp, Llc	200 Clarendon Street Boston MA 02116	No	No	Yes	No
1829166	Bc Perception Holdings, Lp	200 Clarendon Street Boston MA 02116	No	No	Yes	No
1830424	Bain Capital Partners Xii, Llc	200 Clarendon Street Boston MA 02116	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-10-16	5,480,052	$22.81	65,679,781	No	4	P	Indirect	See footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See footnotes

Footnotes

Represents shares of the Issuer's common stock held directly by BC Perception Holdings, LP ("BC Perception"). Bain Capital Fund XII, L.P. ("Fund XII") is the sole member of BCPE Perception GP, LLC ("Perception GP"), which is the general partner of BC Perception. Bain Capital Investors, LLC ("BCI") is the manager of Bain Capital Partners XII, LLC ("Partners XII" and, together with BCI, BC Perception, Fund XII and Perception GP, the "Bain Capital Entities"), which is the general partner of Fund XII. As a result, each of the Bain Capital Entities may be deemed to share voting and dispositive power with respect to the shares of the Issuer's common stock held by BC Perception. Each of the Bain Capital Entities disclaims beneficial ownership of such securities, except to the extent of its pecuniary interest therein.
On October 16, 2023, BC Perception purchased 5,480,052 shares of the Issuer's common stock at a price of $22.81 per share in an underwritten public offering.